DANAHER CORPDRNDANAHER CORPDRNDANAHER CORPDRN

DANAHER CORPDRN

No trades
See on Supercharts

Key facts today

Wolfe Research upgraded Danaher Corporation to 'Outperform' with a price target of $285. Analysts have an average 'Outperform' rating, with targets between $255 and $315.
Analyze the impactAnalyze the impact
Market capitalization
‪1.04 T‬BRL
0.01BRL
‪23.80 B‬BRL
‪119.33 B‬BRL
Beta (1Y)
0.07

About Danaher Corporation


CEO
Rainer M. Blair
Headquarters
Washington
Founded
1984
ISIN
BRDHERBDR004
FIGI
BBG008P6N1G6
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US235851AR3
DANAHER CORP. 15/45
Yield to maturity
5.28%
Maturity date
Sep 15, 2045
D
US23291KAK1
DH EUR.F.II 19/49
Yield to maturity
5.17%
Maturity date
Nov 15, 2049
D
US23291KAJ4
DH EUR.F.II 19/39
Yield to maturity
5.16%
Maturity date
Nov 15, 2039
US235851AV4
DANAHER CORP.20/50
Yield to maturity
5.00%
Maturity date
Oct 1, 2050
DHR5314908
Danaher Corporation 2.8% 10-DEC-2051
Yield to maturity
4.96%
Maturity date
Dec 10, 2051
D
DHR4906001
DH Europe Finance II SARL 2.6% 15-NOV-2029
Yield to maturity
4.64%
Maturity date
Nov 15, 2029
US235851AQ5
DANAHER CORP. 15/25
Yield to maturity
4.48%
Maturity date
Sep 15, 2025
D
XS205114955
DH EUR.F.II. 19/49
Yield to maturity
3.49%
Maturity date
Sep 18, 2049
D
XS205040617
DH EUR.F.II. 19/39
Yield to maturity
3.48%
Maturity date
Sep 18, 2039
XS205040609
DH EUR.F.II. 19/31
Yield to maturity
3.11%
Maturity date
Sep 18, 2031
XS214799537
DANAHER CORP 20/30
Yield to maturity
3.01%
Maturity date
Mar 30, 2030

Explore more bonds 

Curated watchlists where DHER34 is featured.